Botulinum toxin type B for sialorrhea in children with cerebral palsy

Developmental Medicine and Child Neurology

Volumn 53, Issue 6, 2011, Pages 488-489

  Reddihough, Dinah ^a   Graham, H Kerr ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B;

CEREBRAL PALSY; CHILD; DRUG MEGADOSE; DYSPHAGIA; HUMAN; HUMAN RELATION; HYPERSALIVATION; LOW DRUG DOSE; MUSCLE ATROPHY; NOSE FEEDING; NOTE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SALIVARY GLAND; SELF ESTEEM; SEROTYPE; SOCIALIZATION; WEAKNESS;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; CEREBRAL PALSY; HUMANS; SIALORRHEA;

EID: 79955990020     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2011.03977.x     Document Type: Note

References (7)

1. Hallett KB, Lucas JO, Johnston T, Reddihough DS, Hall RK. Dental health of children with cerebral palsy following sialodochoplasty. Spec Care Dentist 1995; 15: 234-8.
2. Basciani M, Di Rienzo F, Fontana A, Copetti M, Pellegrini F, Intiso D. Botulinum toxin type B for sialorrhoea in children with cerebral palsy: a randomized trial comparing three doses. DOI:. (Published online).
3. Rossi RP, Strax TE, Di Rocco A, Rossi RP, Strax TE, Di Rocco A. Severe Dysphagia after botulinum toxin B injection to the lower limbs and lumbar paraspinal muscles. Am J Phys Med Rehabil 2006; 85: 1011-3.
4. Reddihough D, Erasmus CE, Johnson H, McKellar GMW, Jongerius PH. Botulinum toxin assessment, intervention and aftercare for paediatric and adult drooling: international consensus statement. Eur J Neurol 2010; 17 (Suppl 2): 109-21.
5. Dressler D, Benecke R, Dressler D, Benecke R. Pharmacology of therapeutic botulinum toxin preparations. Disabil Rehabil 2007; 29: 1761-8.
6. Wilken B, Aslami B, Backes H. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B. Neuropediatrics 2008; 39: 200-4.
7. Fortuna RVM, Youssef AR, Longino D, Herzog W. Changes in contractile properties of muscles receiving repeat injections of botulinum toxin (Botox). J Biomech 2011; 44: 39-44.